JPMorgan Chase & Co’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-8,231
| Closed | -$97K | – | 5279 |
|
|
2020
Q3 | $97K | Sell |
8,231
-91,955
| -92% | -$1.08M | ﹤0.01% | 4062 |
|
|
2020
Q2 | $1.3M | Sell |
100,186
-1,993
| -2% | -$25.9K | ﹤0.01% | 2893 |
|
|
2020
Q1 | $946K | Sell |
102,179
-13,174
| -11% | -$122K | ﹤0.01% | 2970 |
|
|
2019
Q4 | $1.92M | Buy |
115,353
+656
| +0.6% | +$10.9K | ﹤0.01% | 2726 |
|
|
2019
Q3 | $1.91M | Buy |
114,697
+20,343
| +22% | +$338K | ﹤0.01% | 2762 |
|
|
2019
Q2 | $1.3M | Buy |
94,354
+3,157
| +3% | +$43.4K | ﹤0.01% | 2919 |
|
|
2019
Q1 | $1.57M | Buy |
91,197
+70,976
| +351% | +$1.22M | ﹤0.01% | 2784 |
|
|
2018
Q4 | $259K | Sell |
20,221
-60,042
| -75% | -$769K | ﹤0.01% | 3690 |
|
|
2018
Q3 | $1.3M | Buy |
80,263
+14,904
| +23% | +$242K | ﹤0.01% | 3011 |
|
|
2018
Q2 | $842K | Buy |
65,359
+45,805
| +234% | +$590K | ﹤0.01% | 3224 |
|
|
2018
Q1 | $243K | Buy |
19,554
+14,092
| +258% | +$175K | ﹤0.01% | 3656 |
|
|
2017
Q4 | $76K | Buy |
+5,462
| New | +$76K | ﹤0.01% | 4001 |
|
|
2017
Q2 | – | Sell |
-30,468
| Closed | -$472K | – | 4608 |
|
|
2017
Q1 | $472K | Sell |
30,468
-12,382
| -29% | -$192K | ﹤0.01% | 3179 |
|
|
2016
Q4 | $641K | Buy |
+42,850
| New | +$641K | ﹤0.01% | 3160 |
|